表紙
市場調查報告書

病患監測解決方案的全球市場 - 各產品、用途、終端用戶、各國資料、產業考察、競爭情形:分析與預測 (2019-2028年)

Global Patient Monitoring Solutions Market: Focus on Products, Applications, End-user, Countries Data, Industry Insights and Competitive Landscape - Analysis and Forecast, 2019-2028

出版商 BIS Research Inc. 商品編碼 920204
出版日期 內容資訊 英文 260 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
病患監測解決方案的全球市場 - 各產品、用途、終端用戶、各國資料、產業考察、競爭情形:分析與預測 (2019-2028年) Global Patient Monitoring Solutions Market: Focus on Products, Applications, End-user, Countries Data, Industry Insights and Competitive Landscape - Analysis and Forecast, 2019-2028
出版日期: 2019年12月11日內容資訊: 英文 260 Pages
簡介

全球病患監測解決方案市場規模,至2028年預計將達到361億3,000萬美元的規模。該市場在2019年∼2028年的預測期間內,預計將以 6.50%的年複合成長率 (CAGR) 成長。由於遠程監控設備的引進率上升,老年人口增加,及慢性疾病的罹患率上升,病患監測解決方案市場飛躍性地擴大。該市場的主要課題,是技術成本高,監測設備相關風險,及患者資料的安全、健康資訊的安全性擔憂等。對來自醫院以外環境的監測設備的需求擴大及醫療保健IT的投資成為對供應商來說的大機會。

本報告涵括全球病患監測解決方案市場,提供市場動態,競爭環境,各市場區隔、各地區的市場,競爭情形,及主要企業等相關之詳細分析。

摘要整理

第1章 市場概要

第2章 市場動態

  • 簡介
  • 影響分析
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會

第3章 競爭情形

  • 主要策略、發展
  • 市場佔有率分析

第4章 產業考察

  • 專利分析
  • 法規的必要條件
  • 法律等

第5章 全球病患監測解決方案市場:各產品

  • 血液動態監測設備
  • 心臟監測設備
  • 呼吸監測設備
  • 神經監測設備
  • 糖尿病監測設備
  • 體溫監測設備

第6章 全球病患監測解決方案市場:各用途

  • 血液學
  • 心臟病
  • 呼吸系統
  • 神經學
  • 代謝
  • 體溫

第7章 全球病患監測解決方案市場:各終端用戶

  • 住院患者
  • 門診病人
  • 家庭患者

第8章 全球病患監測解決方案市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第9章 企業簡介

  • 概要
  • Medtronic plc
  • General Electric Company
  • Koninklijke Philips N.V.
  • Dragerwerk AG & Co. KGaA
  • Abbott Laboratories
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • 日本光電
  • OMRON
  • Bosch Limited
  • Becton, Dickinson and Company
  • Biotronik
  • Welch Allyn
  • Smiths Medical, Inc.
  • Getinge AB
  • Spacelabs Healthcare

第10章 調查範圍、手法

目錄
Product Code: BH190A

"Global Patient Monitoring Solutions Market to Reach $36.13 Billion by 2028."

Key Questions Answered in the Report:

  • What are the major market drivers, challenges, and opportunities in the global patient monitoring solutions market?
  • What is the global patient monitoring solutions market size in terms of revenue from 2018-2028?
  • How is each segment of the global patient monitoring solutions market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2028?
  • What are the key development strategies implemented by the key major players to sustain in the competitive market?
  • What is the growth potential of the patient monitoring solutions market in each region, namely, North America, Europe, Asia-Pacific, and the Rest-of-the-World?
  • Which products (hemodynamic, cardiac, respiratory, and neuromonitoring devices) are offered by key players such as GE Healthcare, Medtronic plc, Biotronik Scientific Corporation, Koninklijke Philips N.V., and Johnson & Johnson?
  • What is the market share of major companies in the global patient monitoring solutions market?
  • Which product is currently dominating the global patient monitoring solutions market and why?
  • Which application and end-user of the global patient monitoring solutions market is dominant in the forecast period?

Global Patient Monitoring Solutions Market Forecast, 2019-2028

The Global Patient Monitoring Solutions Market report by BIS Research projects the market to grow at a significant CAGR of 6.50% during the forecast period from 2019 to 2028. The market has evolved dramatically with the rise in adoption rate of remote monitoring devices, increasing number of geriatric populations, and growing prevalence of chronic diseases. Despite the benefits offered by the patient monitoring technology, the major challenges in the market are high cost of technology, risks associated with monitoring devices and lack of security of patient data and health information safety concerns. Some of the major opportunities for the key vendors in the market could be growing demand for monitoring devices from in non-hospital settings and growing investments in healthcare IT.

Expert Quote

"North America is the leading contributor to the global patient monitoring solutions market. In 2018, in terms of revenue, the North America patient monitoring solutions market is anticipated to grow at a significant CAGR during the forecast period. This double-digit growth can be attributed to the rising demand for home-based monitoring devices and increasing investment in healthcare IT. However, Asia-Pacific is the fastest-growing region during the forecast period, because of the rising prevalence of chronic diseases such as diabetes, and hypertension and rising demand for home-based monitoring devices."

Scope of the Global Patient Monitoring Solutions Market

The purpose of this study is to gain a holistic view of the global patient monitoring solutions market in terms of various influencing factors such as regional adoption trends, and technological advancements.

The scope of this report constitutes an in-depth study of the global patient monitoring solutions market, including a thorough analysis of the products in the market as well as their adoption spanning different geographical regions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

Market Segmentation

The global patient monitoring solutions market is segmented based on products (hemodynamic, cardiac, neuromonitoring, respiratory, diabetes, and temperature monitoring device), applications (hematology, cardiology, respiratory, neurology, metabolics, and temperature), and end-user (hospital-based patients, ambulatory based patients, and home healthcare patients), and region (North America, Europe, Asia-Pacific, and Rest-of-the-World (Latin America and Middle East & Africa).

As of 2018, the global patient monitoring solutions market was estimated to be approximately $19.30 billion and is expected to grow with a double-digit CAGR during the forecast period. North America dominated the patient monitoring solutions market among other regions.

Factors contributing to the growth of the North America patient monitoring solutions market include rising demand for home-based monitoring devices and increasing investment in healthcare IT. Asia-Pacific held the second largest contributor for the patient monitoring solutions market, due to the increasing prevalence of chronic conditions such as diabetes and hypertension and rising demand for home-based monitoring devices.

By Product, cardiac monitoring device held 24.62% of the total market share in 2018 and is expected to grow in the upcoming years. The growth in the segment can be attributed to the availability of blood pressure measuring devices in the hospitals, coupled with other factors.

By applications, hematology segment held the largest market share followed by cardiology segment in 2018. By End-User, the hospital-based patients' segment is however expected to dominate the market attributing to the patients undergo surgery in the hospitals and hence they need continuous monitoring of the vital signs and their disease condition. Therefore, increasing usage of monitoring devices to the hospital-based patients.

Key Companies in the Global Patient Monitoring Solutions Market

The report also profiles 19 key players from the patient monitoring solutions market. Some of the market players include primary and secondary data analysis tools providers such as Medtronic plc, Koninklijke Philips N.V., Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Company, Omron Corporation, Nihon Kohden Corporation, Boston Scientific Corporation, and Biotronik. There are a plethora of companies providing different products such as Medtronic plc, Natus Medical, and Dragerwerk AG & Co. KGaA.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Introduction

2 Market Dynamics

  • 2.1 Introduction
  • 2.2 Impact Analysis
  • 2.3 Market Drivers
    • 2.3.1 Rise in Adoption Rate of Remote Patient Monitoring Devices/ Availability of Wireless Monitoring Devices
    • 2.3.2 Rising Incidence of Lifestyle and Chronic Diseases
    • 2.3.3 Government Regulations
    • 2.3.4 Ease of Use and Portability Devices to Promote the Growth
    • 2.3.5 Growth in Geriatric Population
  • 2.4 Market Restraints
    • 2.4.1 Resistance from Healthcare Industry Professionals toward the Adoption of Patient Monitoring Systems
    • 2.4.2 High Cost of Technology
    • 2.4.3 Lack of Security of Patient Data and Health Information Safety Concerns
    • 2.4.4 Risks Associated with Monitoring Devices
  • 2.5 Market Opportunities
    • 2.5.1 Growing Demand for Patient Monitoring Devices in Non-Hospital Settings
    • 2.5.2 Emerging Markets
    • 2.5.3 Growing Investments in Healthcare IT

3 Competitive Landscape

  • 3.1 Key Strategies and Developments
    • 3.1.1 Collaborations, Partnerships, and Agreements
    • 3.1.2 Product Launches and Enhancements
    • 3.1.3 Acquisitions
    • 3.1.4 Awards and Fundings
    • 3.1.5 Product Approvals
    • 3.1.6 Business Expansion Activities
  • 3.2 Market Share Analysis
    • 3.2.1 Market Share Analysis (by Company)

4 Industry Insights

  • 4.1 Patent Analysis
  • 4.2 Regulatory Requirements
  • 4.3 Bills, Acts, and Alliances for Patient Monitoring Solution

5 Global Patient Monitoring Solutions Market (by Product)

  • 5.1 Hemodynamic Monitoring Devices
  • 5.2 Cardiac Monitoring Devices
  • 5.3 Respiratory Monitoring Devices
  • 5.4 Neuromonitoring Devices
  • 5.5 Diabetes Monitoring Devices
  • 5.6 Temperature Monitoring Devices

6 Global Patient Monitoring Solutions Market (by Applications)

  • 6.1 Hematology
  • 6.2 Cardiology
  • 6.3 Respiratory
  • 6.4 Neurology
  • 6.5 Metabolics
  • 6.6 Temperature

7 Global Patient Monitoring Solutions Market (by End-User)

  • 7.1 Hospital Based Patients
  • 7.2 Ambulatory Based Patients
  • 7.3 Home Healthcare Patients

8 Global Patient Monitoring Solutions Market (by Region)

  • 8.1 North America
    • 8.1.1 North America: Patient Monitoring Solutions Market (by Country)
      • 8.1.1.1 U.S.
      • 8.1.1.2 Canada
  • 8.2 Europe
    • 8.2.1 Europe: Patient Monitoring Solutions Market (by Country)
      • 8.2.1.1 Germany
      • 8.2.1.2 U.K.
      • 8.2.1.3 France
      • 8.2.1.4 Italy
      • 8.2.1.5 Spain
      • 8.2.1.6 Netherlands
      • 8.2.1.7 Rest-of-Europe
  • 8.3 Asia-Pacific (APAC)
    • 8.3.1 Asia-Pacific: Patient Monitoring Solutions Market (by Country)
      • 8.3.1.1 Japan
      • 8.3.1.2 China
      • 8.3.1.3 Australia
      • 8.3.1.4 India
      • 8.3.1.5 South Korea
      • 8.3.1.6 Rest-of-Asia-Pacific
  • 8.4 Rest-of-the-World
    • 8.4.1 Rest-of-the-World: Patient Monitoring Solutions Market (by Country)
      • 8.4.1.1 Latin America
      • 8.4.1.2 Middle East & Africa

9 Company Profiles

  • 9.1 Overview
  • 9.2 Medtronic plc
    • 9.2.1 Company Overview
    • 9.2.2 Role of Medtronic plc in the Global Patient Monitoring Solutions Market
    • 9.2.3 Financials
    • 9.2.4 Key Insights about Financial Health of the Company
    • 9.2.5 SWOT Analysis
  • 9.3 General Electric Company
    • 9.3.1 Company Overview
    • 9.3.2 Role of General Electric in the Global Patient Monitoring Solutions Market
    • 9.3.3 Financials
    • 9.3.4 Key Insights on the Financial Health of the Company
    • 9.3.5 SWOT Analysis: General Electric Company
  • 9.4 Koninklijke Philips N.V.
    • 9.4.1 Company Overview
    • 9.4.2 Role of Koninklijke Philips N.V. in the Global Patient Monitoring Solutions Market
    • 9.4.3 Financials
    • 9.4.4 Key Insights on the Financial Health of the Company
    • 9.4.5 SWOT Analysis: Koninklijke Philips N.V.
  • 9.5 Dragerwerk AG & Co. KGaA
    • 9.5.1 Company Overview
    • 9.5.2 Role of Dragerwerk AG & Co. KGaA in the Global Patient Monitoring Solutions Market
    • 9.5.3 Financials
    • 9.5.4 SWOT Analysis
  • 9.6 Abbott Laboratories
    • 9.6.1 Company Overview
    • 9.6.2 Role of Abbott Laboratories in the Global Patient Monitoring Solutions Market
    • 9.6.3 Financials
    • 9.6.4 Key Insights about Financial Health of the Company
    • 9.6.5 SWOT Analysis
  • 9.7 Johnson & Johnson
    • 9.7.1 Company Overview
    • 9.7.2 Role of Johnson & Johnson in the Global Patient Monitoring Solutions Market
    • 9.7.3 Financials
    • 9.7.4 Key Insights about Financial Health of the Company
    • 9.7.5 SWOT Analysis
  • 9.8 F. Hoffmann-La Roche Ltd
    • 9.8.1 Company Overview
    • 9.8.2 Role of F. Hoffmann-La Roche AG in the Global Patient Monitoring Solutions Market
    • 9.8.3 Financials
    • 9.8.4 Key Insights about Financial Health of the Company
    • 9.8.5 SWOT Analysis
  • 9.9 Boston Scientific Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Role of Boston Scientific Corporation in the Patient Monitoring Solutions Market
    • 9.9.3 Financials
    • 9.9.4 Key Insights about Financial Health of the Company
    • 9.9.5 SWOT Analysis
  • 9.10 Edwards Lifesciences Corporation
    • 9.10.1 Company Overview
    • 9.10.2 Role of Edwards Lifesciences Corporation in the Patient Monitoring Solutions Market
    • 9.10.3 Financials
    • 9.10.4 Key Insights about Financial Health of the Company
    • 9.10.5 SWOT Analysis
  • 9.11 NIHON KOHDEN CORPORATION
    • 9.11.1 Company Overview
    • 9.11.2 Role of NIHON KOHDEN CORPORATION in the Patient Monitoring Solutions Market
    • 9.11.3 Financials
    • 9.11.4 Key Insights about Financial Health of the Company
    • 9.11.5 SWOT Analysis
  • 9.12 Omron Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Role of Omron Corporation in the Global Patient Monitoring Solutions Market
    • 9.12.3 Financials
    • 9.12.4 Key Insights about Financial Health of the Company
    • 9.12.5 SWOT Analysis
  • 9.13 Bosch Limited
    • 9.13.1 Company Overview
    • 9.13.2 Role of Bosch Limited in the Global Patient Monitoring Solutions Market
    • 9.13.3 Financials
    • 9.13.4 Key Insights about Financial Health of the Company
    • 9.13.5 SWOT Analysis
  • 9.14 Becton, Dickinson and Company
    • 9.14.1 Company Overview
    • 9.14.2 Role of Becton, Dickinson and Company in the Global Patient Monitoring Solutions Market
    • 9.14.3 Financials
    • 9.14.4 Key Insights about Financial Health of the Company
    • 9.14.5 SWOT Analysis
  • 9.15 Biotronik
    • 9.15.1 Company Overview
    • 9.15.2 Role of Biotronik in the Global Patient Monitoring Solutions Market
    • 9.15.3 SWOT Analysis
  • 9.16 Welch Allyn
    • 9.16.1 Company Overview
    • 9.16.2 Role of Welch Allyn in the Global Patient Monitoring Solutions Market
    • 9.16.3 SWOT Analysis
  • 9.17 Smiths Medical, Inc.
    • 9.17.1 Company Overview
    • 9.17.2 Role of Smiths Medical, Inc. in the Global Patient Monitoring Solutions Market
    • 9.17.3 SWOT Analysis
  • 9.18 Getinge AB
    • 9.18.1 Company Overview
    • 9.18.2 Role of Getinge AB in the Patient Monitoring Solutions Market
    • 9.18.3 SWOT Analysis
  • 9.19 Spacelabs Healthcare
    • 9.19.1 Company Overview
    • 9.19.2 Role of Spacelabs Healthcare in the Global Patient Monitoring Solutions Market
    • 9.19.3 SWOT Analysis

10 Research Scope and Methodology

  • 10.1 Research Scope
  • 10.2 Research Methodology

List of Tables

  • Table 2.1: Impact Analysis of Market Drivers
  • Table 2.2: Impact analysis of Market Restraints
  • Table 4.1: Global Patient Monitoring Solutions Market: Patent Analysis
  • Table 4.2: List of Major Regulatory Bodies and Associations across the World
  • Table 4.3: Some of the Bills, and Acts for Patient Monitoring Solutions
  • Table 5.1: Competitive Benchmarking by Product

List of Figures

  • Figure 1: Drivers and Restraints of Global Patient Monitoring Solutions Market
  • Figure 2: Share of Key Developments and Strategies, January 2016-September 2019
  • Figure 3: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
  • Figure 4: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
  • Figure 5: Global Patient Monitoring Solutions Market Value, 2017-2028
  • Figure 6: Global Patient Monitoring Solutions Market (by Product):2017-2028
  • Figure 7: Global Patient Monitoring Solutions Market (by Applications): 2017-2028
  • Figure 8: Global Patient Monitoring Solutions Market (by End-User): 2017-2028
  • Figure 9: Global Patient Monitoring Solutions Market (by Region), 2018 and 2028
  • Figure 1.1: Global Patient Monitoring Solutions Market, 2017-2028
  • Figure 2.1: Wireless Sharing of Patient Data
  • Figure 2.2: Percentage of Health Care Spending by Number of Chronic Conditions
  • Figure 2.3: Percentage of Population with Chronic Conditions
  • Figure 2.4: The Centers for Disease Control and Prevention (CDC) Statistics
  • Figure 2.5: Leading Chronic Diseases
  • Figure 2.6: Percentage of Chronic Conditions
  • Figure 2.7: Remote Patient Monitoring
  • Figure 3.1: Competitive Landscape, January 2016-September 2019.
  • Figure 3.2: Key Strategies and Developments, January 2016-September 2019.
  • Figure 3.3: Share of Key Developments and Strategies, January 2016-September 2019
  • Figure 3.4: Collaborations, Partnerships, and Agreements share (by Company), January 2016-September 2019
  • Figure 3.5: Product Launches and Enhancements Share (by Company), January 2016-September 2019
  • Figure 3.6: Acquisitions share (by Company), January 2016-September 2019
  • Figure 3.7: Product Launches and Enhancements share (by Company), January 2016-September 2019
  • Figure 3.8: Product Approvals share (by Company), January 2016-September 2019
  • Figure 3.9: Business Expansion and Others share (by Company), January 2016-
  • Figure 3.10: Market Share Analysis for the Global Patient Monitoring Solutions Market, by Company (2018)
  • Figure 5.1: Global Patient Monitoring Solutions Market (by Product)
  • Figure 5.2: Global Patient Monitoring Solutions Market (by Product), 2017-2028
  • Figure 5.3: Global Patient Monitoring Solutions Market: Hemodynamic Monitoring Devices: 2017-2028
  • Figure 5.4: Global Patient Monitoring Solutions Market: Cardiac Monitoring Devices: 2017-2028
  • Figure 5.5: Global; Patient Monitoring Solutions Market: Respiratory Monitoring Devices: 2017-2028
  • Figure 5.6: Global; Patient Monitoring Solutions Market: Neuromonitoring Devices: 2017-2028
  • Figure 5.7: Global Patient Monitoring Solutions Market: Diabetes Monitoring Devices: 2017-2028
  • Figure 5.8: Global; Patient Monitoring Solutions Market: Temperature Monitoring Devices: 2017-2028
  • Figure 6.1: Segmentation of Patient Monitoring Solutions Market, by Applications
  • Figure 6.2: Global Patient Monitoring Solutions Market (by Applications), 2017-2028
  • Figure 6.3: Global Patient Monitoring Solutions Market: Hematology: 2017-2028
  • Figure 6.4: Global Patient Monitoring Solutions Market: Cardiology: 2017-2028
  • Figure 6.5: Global Patient Monitoring Solutions Market: Respiratory: 2017-2028
  • Figure 6.6: Global Patient Monitoring Solutions Market: Neurology: 2017-2028
  • Figure 6.7: Global Patient Monitoring Solutions Market: Metabolics: 2017-2028
  • Figure 6.8: Global Patient Monitoring Solutions Market: Temperature: 2017-2028
  • Figure 7.1: Segmentation of Patient Monitoring Solutions Market, by End-User
  • Figure 7.2: Global Patient Monitoring Solutions Market (by End-User), 2017-2028
  • Figure 7.3: Global Patient Monitoring Solutions Market: Hospital Based Patients: 2017-2028
  • Figure 7.4: Global Patient Monitoring Solutions Market: Ambulatory Patients: 2017-2028
  • Figure 7.5: Global Patient Monitoring Solutions Market: Home Healthcare Patients: 2017-2028
  • Figure 8.1: Global Patient Monitoring Solutions Market (by Region), 2018 and 2028
  • Figure 8.2: North America: Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.3: North America: Market Dynamics
  • Figure 8.4: North America: Patient Monitoring Solutions Market (by Country), 2018 and 2028
  • Figure 8.5: The U.S.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.6: Canada Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.7: Europe Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.8: Europe: Market Dynamics
  • Figure 8.9: Europe: Patient Monitoring Solutions Market (by Country), 2018 and 2028
  • Figure 8.10: Germany: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.11: U.K.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.12: France: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.13: Italy: Patient monitoring Solutions Market: 2017-2028
  • Figure 8.14: Spain.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.15: Netherlands: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.16: Rest-of-the-Europe: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.17: Asia-Pacific: Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.18: Asia-Pacific: Market Dynamics
  • Figure 8.19: Asia-Pacific: Patient Monitoring Solutions Market (by Country), 2018 and 2028
  • Figure 8.20: Japan.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.21: China: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.22: Australia.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.23: India: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.24: South Korea: Patient Monitoring Solutions Market: 2017-2028
  • Figure 8.25: Rest-of-Asia-Pacific: Patient monitoring solutions Market: 2017-2028
  • Figure 8.26: Rest-of-the-World: Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.27: Rest-of-the-World: Market Dynamics
  • Figure 8.28: Rest-of-the-World: Patient Monitoring Solutions Market (by Country), 2018 and 2028
  • Figure 8.29: Latin America Patient Monitoring Solutions Market, 2017-2028
  • Figure 8.30: Middle East & Africa.: Patient Monitoring Solutions Market: 2017-2028
  • Figure 9.1: Shares of Key Companies Profile
  • Figure 9.2: Medtronic plc: Overall Product Portfolio
  • Figure 9.3: Medtronic plc: Overall Financials, 2016-2018
  • Figure 9.4: Medtronic plc: Revenue (by Product and Services), 2016-2018
  • Figure 9.5: Medtronic plc: Revenue (by Region), 2016-2018
  • Figure 9.6: Medtronic plc: R&D Expenditure, 2016-2018
  • Figure 9.7: Medtronic plc: SWOT Analysis
  • Figure 9.8: General Electric Company: Overall Product Portfolio
  • Figure 9.9: General Electric Company: Overall Financials, 2016-2018
  • Figure 9.10: General Electric Company Net Revenue (by Business Segment), 2016-2018
  • Figure 9.11: General Electric Company: Net Revenue (by Region), 2016-2018
  • Figure 9.12: General Electric Company: R&D Expense, 2016-2018
  • Figure 9.13: General Electric Company: SWOT Analysis
  • Figure 9.14: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 9.15: Koninklijke Philips N.V.: Overall Financials, 2016-2018
  • Figure 9.16: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2016-2018
  • Figure 9.17: Koninklijke Philips N.V.: Net Revenue (by Region), 2016-2018
  • Figure 9.18: Koninklijke Philips N.V.: R&D Expense, 2016-2018
  • Figure 9.19: Koninklijke Philips N.V.: SWOT Analysis
  • Figure 9.20: Dragerwerk AG & Co. KGaA: Overall Product Portfolio
  • Figure 9.21: Dragerwerk AG & Co. KGaA: Overall Financials (2016-2018)
  • Figure 9.22: Dragerwerk AG & Co. KGaA: Business Segments (2016-2018)
  • Figure 9.23: Dragerwerk AG & Co. KGaA: Net Sales by Region (2016-2018)
  • Figure 9.24: Percent Sales from each Region in 2017
  • Figure 9.25: Dragerwerk AG & Co. KGaA: SWOT Analysis
  • Figure 9.26: Abbott Laboratories: Overall Product Portfolio
  • Figure 9.27: Abbott Laboratories: Overall Financials, 2016-2018
  • Figure 9.28: Abbott Laboratories: Revenue (by Product and Services), 2016-2018
  • Figure 9.29: Abbott Laboratories: Revenue (by Region), 2016-2018
  • Figure 9.30: Abbott Laboartories: R&D Expenditure, 2016-2018

List of Figures

  • Figure 9.32: Johnson & Johnson: Overall Product Portfolio
  • Figure 9.33: Johnson & Johnson: Overall Financials, 2017-2019
  • Figure 9.34: Johnson & Johnson: Revenue (by Product and Services), 2016-2018
  • Figure 9.35: Johnson & Johnson: Revenue (by Region), 2016-2018
  • Figure 9.36: Johnson & Johnson: R&D Expenditure, 2016-2018
  • Figure 9.37: Johnson & Johnson: SWOT Analysis
  • Figure 9.38: F. Hoffmann-La Roche AG: Overall Product Portfolio
  • Figure 9.39: F. Hoffmann-La Roche AG: Overall Financials, 2016-2018
  • Figure 9.40: F. Hoffmann-La Roche AG: Revenue (by Segment), 2016-2018
  • Figure 9.41: F. Hoffmann-La Roche Ltd: Revenue Split for Diagnostics, 2016-2018
  • Figure 9.42: F. Hoffmann-La Roche AG: Revenue (by Region), 2016-2018
  • Figure 9.43: F. Hoffmann-La Roche AG: R&D Expenditure, 2016-2018
  • Figure 9.44: F. Hoffmann-La Roche AG: SWOT Analysis
  • Figure 9.45: Boston Scientific Corporation: Overall Product Portfolio
  • Figure 9.46: Boston Scientific Corporation Overall Financials, 2016-2019
  • Figure 9.47: Boston Scientific Corporation: Revenue (by Product and Services), 2016-2018
  • Figure 9.48: Boston Scientific Corporation: Revenue (by Region), 2016-2018
  • Figure 9.49: Boston Scientific Corporation: R&D Expenditure, 2016-2018
  • Figure 9.50: Boston Scientific Corporation: SWOT Analysis
  • Figure 9.51: Edwards Lifesciences Corporation: Overall Product Portfolio
  • Figure 9.52: Edwards Lifesciences Corporation Overall Financials, 2016-2018
  • Figure 9.53: Edwards Lifesciences Corporation: Revenue (by Product and Services), 2016-2018
  • Figure 9.54: Edwards Lifesciences Corporation: Revenue (by Region), 2016-2018
  • Figure 9.55: Edwards Lifesciences Corporation: R&D Expenditure, 2016-2018
  • Figure 9.56: Edwards Lifesciences Corporation: SWOT Analysis
  • Figure 9.57: NOHON KOHDEN CORPORATION: Overall Product Portfolio
  • Figure 9.58: NIHON KOHDEN CORPORATION Overall Financials, 2017-2019
  • Figure 9.59: NIHON KOHDEN CORPORATION: Revenue (by Product and Services), 2016-2018
  • Figure 9.60: NIHON KOHDEN CORPORATION: Revenue (by Region), 2016-2018
  • Figure 9.61: NOHON KOHDEN CORPORATION: R&D Expenditure, 2016-2018
  • Figure 9.62: NIHON KOHDEN CORPORATION: SWOT Analysis
  • Figure 9.63: Omron Corporation: Overall Product Portfolio
  • Figure 9.64: Omron Corporation: Overall Financials, 2016-2019
  • Figure 9.65: Omron Corporation: Revenue (by Product and Services), 2016-2018
  • Figure 9.66: Omron Corporation: Revenue (by Region), 2016-2018
  • Figure 9.67: Omron Corporation: R&D Expenditure, 2016-2018
  • Figure 9.68: Omron Corporation: SWOT Analysis
  • Figure 9.69: Bosch Limited: Overall Product Portfolio
  • Figure 9.70: Bosch Limited Overall Financials, 2016-2019
  • Figure 9.71: Bosch Limited: Revenue (by Product and Services), 2016-2018
  • Figure 9.72: Bosch Limited: Revenue (by Region), 2016-2018
  • Figure 9.73: Bosch Limited: R&D Expenditure, 2016-2018
  • Figure 9.74: Bosch Limited: SWOT Analysis
  • Figure 9.75: Becton, Dickinson & Company: Overall Product Portfolio
  • Figure 9.76: Becton, Dickinson & Company Overall Financials, 2016-2019
  • Figure 9.77: Becton, Dickinson & Company: Revenue (by Product and Services), 2016-2018
  • Figure 9.78: Becton, Dickinson & Company: Revenue (by Region), 2016-2018
  • Figure 9.79: Becton, Dickinson & Company: R&D Expenditure, 2016-2018
  • Figure 9.80: Becton, Dickinson & Company: SWOT Analysis
  • Figure 9.81: Biotronik: Overall Product Portfolio
  • Figure 9.82: Biotronik: SWOT Analysis
  • Figure 9.83: Welch Allyn: Overall Product Portfolio
  • Figure 9.84: Welch Allyn: SWOT Analysis
  • Figure 9.85: Smiths Medical, Inc: Overall Product Portfolio
  • Figure 9.86: Smiths Medical, Inc.: SWOT Analysis
  • Figure 9.87: Getinge AB: Overall Product Portfolio
  • Figure 9.88: Getinge AB: SWOT Analysis
  • Figure 9.89: Spacelabs Healthcare: Overall Product Portfolio
  • Figure 9.90: Spacelabs Healthcare: SWOT Analysis
  • Figure 10.1: Global Patient Monitoring Solutions: Market Segmentation
  • Figure 10.2: Global Patient Monitoring Solutions Market
  • Figure 10.3: Data Triangulation
  • Figure 10.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 10.5: Bottom-up Approach (Segment-wise Analysis)
  • Figure 10.6: Assumptions and Limitations
  • Figure 10.7: Data and Prediction Modeling
Back to Top